<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FT934-8186</title>
	</head>
	<body>
		<main>
			<p>931117 FT  17 NOV 93 / FTC looks into drug mergers A US Federal Trade Commission official yesterday confirmed the agency was investigating pharmaceutical company mergers, drug prices and efforts to stall market entries by competitors, Reuter reports from Washington. Mr Mark Witner, the FTC's acting deputy director, bureau of competition, told the Senate Ageing Committee the commission had recently conducted investigations of horizontal and vertical mergers in the drug industry. 'Some of these investigations continue,' he said. The commission is also investigating alleged price discrimination in prescription drug distribution, he added. 'We are also examining in another investigation, the possibility that an incumbent firm has abused regulatory processes in order to defeat or retard market entry by a competitor.'</p>
		</main>
</body></html>
            